To comply with FTC regulations, all links could lead to commissions paid to the publisher. Please see Advertising Disclosure in sidebar.
WASHINGTON, D.C. – A new scientific study states that the Moderna-manufactured COVID-19 vaccine carries at least double the risk of myocarditis – otherwise known as heart inflammation – than its Pfizer counterpart, with young men being the demographic that is most at risk of contracting the ailment.
The study – which was published in the Journal of the American College of Cardiology – was headed up by epidemiologist and executive director of analytics at the British Columbia Centre for Disease Control Naveed Janjua, was entitled “Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNAN-1273 Coronavirus Vaccines.”
Janjua noted in his conclusions that the second dose of the Moderna vaccine, on average, produced 269 cases of myocarditis in every one million fully- vaccinated individuals from the ages of 18 through 29; in contrast, the Pfizer vaccine only produced 58 cases per one million in the same age range.
In addition, 27.6 percent of women in the 18 to 39 age group experienced myocarditis after they had received two full doses of the Moderna vaccine.
FREE DIGITAL SUBSCRIPTION: GET ONLY 'FEATURED' STORIES BY EMAIL
Big Tech is using a content filtering system for online censorship. Watch our short video about NewsGuard to learn how they control the narrative for the Lamestream Media and help keep you in the dark. NewsGuard works with Big-Tech to make it harder for you to find certain content they feel is 'missing context' or stories their editors deem "not in your best interest" - regardless of whether they are true and/or factually accurate. They also work with payment processors and ad-networks to cut off revenue streams to publications they rate poorly by their same bias standards. This should be criminal in America. You can bypass this third-world nonsense by signing up for featured stories by email and get the good stuff delivered right to your inbox.
“Postmarketing evaluations have linked myocarditis to COVID-19 mRNA vaccines,” the study’s introduction read. “However, few population-based analyses have directly compared the safety of the 2 mRNA COVID-19 vaccines.”
Instances of myocarditis dipped significantly in older age groups of both males and females, the study noted, but concluded that younger people were put at greater risk of heart inflammation if they had received both doses of the Moderna jab.
Chances of developing pericarditis – the swelling and irritation of the thin, saclike tissue surrounding the heart – are possibly increased by both the Pfizer and Moderna vaccines as well, the study said.
The study, conducted amongst 3.1 million people – some of which were administered the Moderna vaccine, while others received Pfizer – saw 59 participants developing myocarditis and 41 developing pericarditis; the malady developed twice as much with the Moderna jab, researchers said.